Oncolytics Biotech Inc.ONCYNASDAQ
Loading
Free Cash Flow Growth Under PressureDecelerating
Percentile Rank36
Year-over-Year Change
Year-over-year free cash flow growth rate
Percentile
P36
Within normal range
vs 5Y Ago
-11x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | -21.70% |
| Q2 2025 | 15.80% |
| Q1 2025 | 17.24% |
| Q4 2024 | -61.43% |
| Q3 2024 | 30.26% |
| Q2 2024 | 7.20% |
| Q1 2024 | -22.65% |
| Q4 2023 | -1.61% |
| Q3 2023 | 28.77% |
| Q2 2023 | -8.05% |
| Q1 2023 | -31.93% |
| Q4 2022 | -39.53% |
| Q3 2022 | 38.58% |
| Q2 2022 | -10.19% |
| Q1 2022 | 1.91% |
| Q4 2021 | -62.80% |
| Q3 2021 | 42.12% |
| Q2 2021 | -22.18% |
| Q1 2021 | 2.84% |
| Q4 2020 | 6.63% |
| Q3 2020 | 1.96% |
| Q2 2020 | -57.88% |
| Q1 2020 | 45.34% |
| Q4 2019 | -60.64% |
| Q3 2019 | 5.02% |
| Q2 2019 | -40.34% |
| Q1 2019 | 22.66% |
| Q4 2018 | -23.54% |
| Q3 2018 | -742.73% |
| Q2 2018 | 111.86% |
| Q1 2018 | -43.84% |
| Q4 2017 | -1.60% |
| Q3 2017 | 31.25% |
| Q2 2017 | -17.16% |
| Q1 2017 | -3.39% |
| Q4 2016 | -26.22% |
| Q3 2016 | -15.19% |
| Q2 2016 | 13.06% |
| Q1 2016 | 30.86% |
| Q4 2015 | -52.07% |